CRISPR Therapeutics Presents Zugo-cel Lymphoma Data at ASH Annual Meeting

Bitget2026/11/04 14:11

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

CRISPR Therapeutics will present zugo-cel clinical data at the American Society of Hematology annual meeting, Dec. 12-15, 2026.
The oral presentation is scheduled for Dec. 13 at 5:15 p.m. CST, covering Phase 1/2 results in relapsed or refractory large B-cell lymphoma.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611040901PRIMZONEFULLFEED9869871) on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

CRISPR Therapeutics Presents Zugo-cel Lymphoma Data at ASH Annual Meeting

You may also like

Crypto prices